Aclaris Therapeutics, Inc.
2021 Q2 - 2025 Q4 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 87 | 0.0% | 28,998 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 48 | 0.0% | 34,131 | 6/30/2025 |
| 2024 Q1 | 5/14/2024 | 18 | 0.0% | 14,788 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 17 | 0.0% | 15,960 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 192 | 0.0% | 27,974 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 285 | 0.0% | 27,467 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 202 | 0.0% | 24,926 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 393 | 0.0% | 24,926 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 368 | 0.0% | 23,387 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 333 | 0.0% | 23,835 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 365 | 0.0% | 21,195 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 385 | 0.0% | 26,495 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 478 | 0.0% | 26,579 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 434 | 0.0% | 24,715 | 6/30/2021 |